Future studies employing chemerin-KO mice in well-established pulmonary fibrosis models (e.g., bleomycin-induced fibrosis) are therefore warranted to clarify the in vivo contribution of chemerin to fibrotic lung pathogenesis [70,71,72,73,74]. The gene discussed is RARRES2; the disease is fibrosis.